Never trust Sam Altman.

Even if yall don’t train off it he’ll find some other way.

“In one example, [Friar] pointed to drug discovery: if a pharma partner used OpenAI technology to help develop a breakthrough medicine, [OpenAI] could take a licensed portion of the drug's sales”

https://www.businessinsider.com/openai-cfo-sarah-friar-futur...